OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species
Linggang Zheng, Yang Tan, Yucan Hu, et al.
ACS Synthetic Biology (2022) Vol. 11, Iss. 1, pp. 464-472
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Nikhil Aggarwal, Shohei Kitano, Ginette Ru Ying Puah, et al.
Chemical Reviews (2022) Vol. 123, Iss. 1, pp. 31-72
Open Access | Times Cited: 167

Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target
Kai Wang, Zhiwei Zhang, Jing Hang, et al.
Science (2023) Vol. 381, Iss. 6657
Open Access | Times Cited: 69

Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Qixing Nie, Xi Luo, Kai Wang, et al.
Cell (2024) Vol. 187, Iss. 11, pp. 2717-2734.e33
Open Access | Times Cited: 55

Bacteroides and related species: The keystone taxa of the human gut microbiota
Jae Hyun Shin, Glenn Tillotson, Tiffany N. MacKenzie, et al.
Anaerobe (2024) Vol. 85, pp. 102819-102819
Open Access | Times Cited: 36

Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation
Mohammad Arifuzzaman, Nicholas Collins, Chun‐Jun Guo, et al.
Immunity (2024) Vol. 57, Iss. 1, pp. 14-27
Open Access | Times Cited: 31

The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice
Chuyu Yun, Sen Yan, Baoying Liao, et al.
Nature Metabolism (2024) Vol. 6, Iss. 5, pp. 947-962
Closed Access | Times Cited: 15

Unraveling the gut-Lung axis: Exploring complex mechanisms in disease interplay
Mariam Wed Eladham, Balachandar Selvakumar, Narjes Saheb Sharif‐Askari, et al.
Heliyon (2024) Vol. 10, Iss. 1, pp. e24032-e24032
Open Access | Times Cited: 8

Depression-associated gut microbes, metabolites and clinical trials
Meiling Wang, Zhaoqi Song, Shirong Lai, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7

Innovative Delivery System Combining CRISPR-Cas12f for Combatting Antimicrobial Resistance in Gram-Negative Bacteria
Tengfei Long, Shiying Zhou, Zilei Huang, et al.
ACS Synthetic Biology (2024) Vol. 13, Iss. 6, pp. 1831-1841
Closed Access | Times Cited: 6

Distribution of bacterial DNA repair proteins and their co-occurrence with immune systems
Sumanth Mutte, Patrick Barendse, Pilar Bobadilla Ugarte, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115110-115110
Open Access

Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species
Zepeng Qu, Hongbin Liu, Yang Ji, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Multi-Omics Unveils Strain-Specific Neuroactive Metabolite Production Linked to Inflammation Modulation by Bacteroides and Their Extracellular Vesicles
Basit Yousuf, Walid Mottawea, Galal Ali Esmail, et al.
Current Research in Microbial Sciences (2025), pp. 100358-100358
Open Access

CRISPR-Cas-Based Engineering of Probiotics
Ling Liu, Shimaa Elsayed Helal, Nan Peng
BioDesign Research (2023) Vol. 5
Open Access | Times Cited: 17

Metabolic engineering of human gut microbiome: Recent developments and future perspectives
Peishun Li, Stefan Roos, Hao Luo, et al.
Metabolic Engineering (2023) Vol. 79, pp. 1-13
Open Access | Times Cited: 15

Decoding the microbiome: advances in genetic manipulation for gut bacteria
Ziying Chen, Wen‐Bing Jin, Alex Hoover, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 11, pp. 1143-1161
Closed Access | Times Cited: 15

CRISPR-Cas-based identification of a sialylated human milk oligosaccharides utilization cluster in the infant gut commensal Bacteroides dorei
Sivan Kijner, Dena Ennis, Shimrit Shmorak, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Genome engineering of the human gut microbiome
Linggang Zheng, Juntao Shen, Ruiyue Chen, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2024) Vol. 51, Iss. 5, pp. 479-491
Open Access | Times Cited: 4

Gut microbiota-derived fatty acid and sterol metabolites: biotransformation and immunomodulatory functions
Haohao Zhang, Yadong Xie, Fei Cao, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4

Culturing of a complex gut microbial community in mucin-hydrogel carriers reveals strain- and gene-associated spatial organization
Xiaofan Jin, Feiqiao Brian Yu, Yan Jia, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12

Microbiome modulation in inflammatory diseases: Progress to microbiome genetic engineering
Fatemehsadat Mousavinasab, Reihaneh Karimi, Sima Taheri, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11

Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment
Yan Huang, Lin Xiaojun, Siyang Yu, et al.
ACS Synthetic Biology (2022) Vol. 11, Iss. 10, pp. 3134-3153
Closed Access | Times Cited: 18

Exploring the Probiotic Potential of Bacteroides spp. Within One Health Paradigm
Muhammad Aammar Tufail, Ruth A. Schmitz
Probiotics and Antimicrobial Proteins (2024)
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top